Global Protein Drugs Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Protein Drugs Revenue
• 1.4 Market by Type
  • 1.4.1 Global Protein Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Antibody Drugs
  • 1.4.3 Peptide Hormones
  • 1.4.4 Blood Products
  • 1.4.5 Enzymes
• 1.5 Market by Application
  • 1.5.1 Global Protein Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Protein Drugs Market Perspective (2015-2026)
• 2.2 Global Protein Drugs Growth Trends by Regions
  • 2.2.1 Protein Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Protein Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Protein Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Protein Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Protein Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Protein Drugs Players by Market Size
  • 3.1.1 Global Top Protein Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Protein Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Protein Drugs Market Concentration Ratio
  • 3.2.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2019
• 3.3 Protein Drugs Key Players Head office and Area Served
• 3.4 Key Players Protein Drugs Product Solution and Service
• 3.5 Date of Enter into Protein Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Protein Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Protein Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Protein Drugs Market Size by Application (2015-2020)
• 5.2 Global Protein Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Protein Drugs Market Size (2015-2020)
• 6.2 Protein Drugs Key Players in North America (2019-2020)
• 6.3 North America Protein Drugs Market Size by Type (2015-2020)
• 6.4 North America Protein Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Protein Drugs Market Size (2015-2020)
• 7.2 Protein Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Protein Drugs Market Size by Type (2015-2020)
• 7.4 Europe Protein Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Protein Drugs Market Size (2015-2020)
• 8.2 Protein Drugs Key Players in China (2019-2020)
• 8.3 China Protein Drugs Market Size by Type (2015-2020)
• 8.4 China Protein Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Protein Drugs Market Size (2015-2020)
• 9.2 Protein Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Protein Drugs Market Size by Type (2015-2020)
• 9.4 Japan Protein Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Protein Drugs Market Size (2015-2020)
• 10.2 Protein Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Protein Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Protein Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Protein Drugs Market Size (2015-2020)
• 11.2 Protein Drugs Key Players in India (2019-2020)
• 11.3 India Protein Drugs Market Size by Type (2015-2020)
• 11.4 India Protein Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Protein Drugs Market Size (2015-2020)
• 12.2 Protein Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Protein Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Protein Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Eli Lilly
  • 13.1.1 Eli Lilly Company Details
  • 13.1.2 Eli Lilly Business Overview
  • 13.1.3 Eli Lilly Protein Drugs Introduction
  • 13.1.4 Eli Lilly Revenue in Protein Drugs Business (2015-2020))
  • 13.1.5 Eli Lilly Recent Development
• 13.2 Abbott Laboratories
  • 13.2.1 Abbott Laboratories Company Details
  • 13.2.2 Abbott Laboratories Business Overview
  • 13.2.3 Abbott Laboratories Protein Drugs Introduction
  • 13.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2015-2020)
  • 13.2.5 Abbott Laboratories Recent Development
• 13.3 UCB Group
  • 13.3.1 UCB Group Company Details
  • 13.3.2 UCB Group Business Overview
  • 13.3.3 UCB Group Protein Drugs Introduction
  • 13.3.4 UCB Group Revenue in Protein Drugs Business (2015-2020)
  • 13.3.5 UCB Group Recent Development
• 13.4 Schering-Plough Corporation
  • 13.4.1 Schering-Plough Corporation Company Details
  • 13.4.2 Schering-Plough Corporation Business Overview
  • 13.4.3 Schering-Plough Corporation Protein Drugs Introduction
  • 13.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2015-2020)
  • 13.4.5 Schering-Plough Corporation Recent Development
• 13.5 Genentech
  • 13.5.1 Genentech Company Details
  • 13.5.2 Genentech Business Overview
  • 13.5.3 Genentech Protein Drugs Introduction
  • 13.5.4 Genentech Revenue in Protein Drugs Business (2015-2020)
  • 13.5.5 Genentech Recent Development
• 13.6 Johnson＆Johnson
  • 13.6.1 Johnson＆Johnson Company Details
  • 13.6.2 Johnson＆Johnson Business Overview
  • 13.6.3 Johnson＆Johnson Protein Drugs Introduction
  • 13.6.4 Johnson＆Johnson Revenue in Protein Drugs Business (2015-2020)
  • 13.6.5 Johnson＆Johnson Recent Development
• 13.7 Bristol-Myers Squibb
  • 13.7.1 Bristol-Myers Squibb Company Details
  • 13.7.2 Bristol-Myers Squibb Business Overview
  • 13.7.3 Bristol-Myers Squibb Protein Drugs Introduction
  • 13.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2015-2020)
  • 13.7.5 Bristol-Myers Squibb Recent Development
• 13.8 Novo Nordisk
  • 13.8.1 Novo Nordisk Company Details
  • 13.8.2 Novo Nordisk Business Overview
  • 13.8.3 Novo Nordisk Protein Drugs Introduction
  • 13.8.4 Novo Nordisk Revenue in Protein Drugs Business (2015-2020)
  • 13.8.5 Novo Nordisk Recent Development
• 13.9 Biogen Idec
  • 13.9.1 Biogen Idec Company Details
  • 13.9.2 Biogen Idec Business Overview
  • 13.9.3 Biogen Idec Protein Drugs Introduction
  • 13.9.4 Biogen Idec Revenue in Protein Drugs Business (2015-2020)
  • 13.9.5 Biogen Idec Recent Development
• 13.10 Dendreon Corporation
  • 13.10.1 Dendreon Corporation Company Details
  • 13.10.2 Dendreon Corporation Business Overview
  • 13.10.3 Dendreon Corporation Protein Drugs Introduction
  • 13.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2015-2020)
  • 13.10.5 Dendreon Corporation Recent Development
• 13.11 Amgen Inc.
  • 10.11.1 Amgen Inc. Company Details
  • 10.11.2 Amgen Inc. Business Overview
  • 10.11.3 Amgen Inc. Protein Drugs Introduction
  • 10.11.4 Amgen Inc. Revenue in Protein Drugs Business (2015-2020)
  • 10.11.5 Amgen Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer